About this book:

*Precision Prescriptions: A Clinician's Guide to Personalized Medicine* provides a comprehensive roadmap for integrating genomics, biomarkers, and data analytics into routine clinical practice. Moving beyond the "population average" model, the book details how clinicians can leverage single nucleotide variants, copy number variations, and mitochondrial DNA to tailor interventions in high-impact fields such as oncology, cardiology, and rare diseases. It emphasizes the "bench-to-bedside" interface, offering practical guidance on selecting the appropriate sequencing tests—from targeted panels to whole-genome sequencing—and interpreting results within the rigorous framework of analytical validity, clinical validity, and clinical utility.

The text underscores that precision medicine is as much an informatics and communication discipline as it is a biological one. It provides frameworks for integrating discrete genomic data into electronic health records (EHRs) and implementing clinical decision support (CDS) tools that offer real-time prescribing guidance at the point of care. A significant portion of the book is dedicated to the human element, detailing strategies for communicating uncertainty, such as variants of uncertain significance (VUS), and navigating the psychosocial implications of genetic findings for patients and their families.

From an administrative and systemic perspective, the guide addresses the logistical and ethical complexities of building a sustainable precision medicine program. It covers the essentials of laboratory partnerships, quality management, and the intricate landscape of coding and reimbursement. Furthermore, the book confronts the "diversity gap" in genomic data, advocating for equitable access and inclusive reference datasets to prevent the exacerbation of health disparities. By addressing these systemic hurdles, the book aims to move personalized care from specialized academic centers to broad clinical adoption.

The final chapters explore the cutting edge of the field, including the selection and safety monitoring of gene- and cell-based therapies like CAR T-cell therapy. Looking toward the future, the author envisions a "learning health system" powered by multi-omic integration—combining genomics with proteomics and metabolomics—and real-time digital health data from wearables. Ultimately, the book predicts that the orchestration of these massive datasets by artificial intelligence will enable the creation of "digital twins," allowing for predictive, preventative, and highly personalized care that evolves throughout a patient’s lifetime.